Goldman Sachs’s Medline Inc MDLN Stock Holding History

Goldman Sachs’s Portfolio MDLN Stock Details MDLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$58.7M	Buy	1,319,467 +1,313,012	+20,341%	+$58M	0.01%	1450
2025 Q4	$271K	Buy	+6,455	New	+$273K	﹤0.01%	5914

Other funds holding MDLN

Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return

HFCIX

H&F Corporate Investors X San Francisco, California $3.85B AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

LPC

Lone Pine Capital Greenwich, Connecticut $12.5B AUM 54.4% 1-Year Est. Return

Goldman Sachs's MDLN Position: Q1 2026 in Review

Goldman Sachs increased its Medline Inc (MDLN) stake by 20,341% in Q1 2026, buying an estimated $58M and bringing the position to 1,319,467 shares worth $58.7M. The position accounts for 0.01% of the portfolio, ranked #1450.

Goldman Sachs first reported a position in MDLN in Q4 2025 and has held it in 2 quarters since. 314 funds tracked by Wall St. Rank hold MDLN as of Q1 2026.

Goldman Sachs held 1,319,467 shares of Medline Inc worth $58.7M as of Q1 2026.
Goldman Sachs bought 1,313,012 Medline Inc shares in Q1 2026, an estimated $58M.
Medline Inc made up 0.01% of Goldman Sachs's portfolio in Q1 2026, its #1450 holding.
Goldman Sachs first reported a position in Medline Inc in Q4 2025 and has held it in 2 quarters since.
314 funds tracked by Wall St. Rank held Medline Inc as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.